Board of Directors
Stephane Ducroux
Chief Executive Officer
Stephane Ducroux brings 22 years of international experience in the Natural Specialty Ingredients industry. He is a proven senior executive that has built and led teams towards growth ambitions in a multicultural-international B2B environment. Stephane is a versatile, energetic, hands on and results oriented leader with expertise in acquisitions, integrations, cross functional management & International business development.
In former roles, Stephane was COO at Naturex Americas/Asia-Pacific (18years) & Board Director as well as PureCircle CCO & Deputy CEO.
Keith Thomson
Chief Financial Officer
Keith qualified as a Chartered Accountant with KPMG. He was COO and CFO at Phytopharm plc where he successfully re-structured the business and enabled the company to close a £25 million fundraising. He has helped guide a number of international healthcare businesses including: On Medica an international E-detailing business, Verigen, a German based multinational tissue engineering business, and Vision RT, a business utilising 3D surface imaging technology to improve the efficacy of radiotherapy treatment.
Johan Kamphuis
Non-executive Director
Johan Kamphuis has over 30 years of global experience in the Health Wellness and Functional Food industries. As an experienced and skilled senior executive he has led sales and business development efforts in all markets including North America, EU and Asia-Pacific. His specialty and interest is growing smaller businesses into high growth financially outstanding professional performers in the Nutraceutical Industry. He is the former President of Global Business for OmniActive Health Technologies.
Rob Beudeker
Non-executive Director
Rob Beudeker is currently responsible for the investment in start-up companies active in nutrition as Investment Director at DSM Venturing. From 2010 to 2016, he was active as VP Innovation at Human Nutrition and Health at DSM, steering these activities globally from Switzerland. Prior to this, Rob held various functions in R&D (project-, program- and resource management) and New Business Development at DSM, known as Gist-Brocades at the time he joined in 1984. Before this he worked as a post-doc at the University of Texas in Austin in molecular biology.
Rob has a MSc in biology and PhD in microbiology from the University of Groningen in The Netherlands, as well as a MBA from the Universities of Rotterdam and Rochester (NY). In addition, he is a member of the supervisory board at JavaFoods, Phynova, Frontier Nutrition and S-Biomedic. He also works at TiFN (Wageningen, The Netherlands) as Program Director for Health and Nutrition.
Brett Stacey
Non-executive Director
Brett Stacey has 35 years of global experience in global financial markets. He was instrumental in setting up the derivative markets in South Africa becoming Deputy Chairman of South African Stock Exchange. He was also CEO and founder of the first derivative broking company in South Africa which was ultimately sold to JP Morgan. As a member of the Johannesburg Stock Exchange he was responsible for a number of flotations and was a member of the New Products Committee.
After selling his business in South Africa he moved to the United Kingdom in 2004 and is now a partner in Regent Assay, a Corporate Finance Company which operates in the small to medium sector concentrating on sales of family businesses and raising capital for companies in a growth phase.
Brett holds an accounting degree and has an MBA from the University of Cape Town.
Contact us
